CPA’s Take: CivicaRX CEO Martin VanTrieste explains why it is essential, and achievable to reshore pharmaceutical production to the US. Two years ago, a group of U.S. hospitals launched Civica Rx, a nonprofit generic drug company that I have the honor to lead. Its core mission is to deliver quality medicines at sustainable prices. [Martin Vantrieste…
CPA’s take: It’s great to see the Trump administration invoking the DPA to lend Kodak some serious money, great to see a historic US company getting into the pharma business, and great to see 300 jobs to be created in Rochester NY. The Eastman Kodak Company has secured a $765 million Defense Production Act loan to…
The AFL-CIO, USW, and 19 other groups released a joint statement on bringing PPE manufacturing back to the States. On July 20, a coalition of 21 groups asked the U.S. government to support efforts to invest in domestic production of PPE, or personal protection equipment. The coalition included several manufacturing trade groups and unions, including…
Editor’s Note: Michael Stumo is CEO of the Coalition for a Prosperous America. Follow him at @michael_stumo The coronavirus pandemic has revealed a troubling truth: Global supply chains operated by stateless multinational corporations simply aren’t reliable. Americans are learning this in real-time as they see imports from China cut off, particularly for critical medicines and pharmaceuticals.…
By Steven L. Byers, PhD and Jeff Ferry The US is in the midst of a public health crisis and the country is struggling with shortages of essential health care supplies. In most cases, these shortages are linked to our excessive reliance on imported supplies, which are arriving in much smaller quantities than ordered, if…
Health, Security, Economic Benefits from Reshoring By Steven L. Byers, PhD and Jeff Ferry With the spreading coronavirus pandemic, Americans are becoming increasingly aware of our dependence on foreign sources for important pharmaceuticals and other health care products. The US is dependent on China for over one third of all the antibiotics we import, and…
Excerpt: How did the pharmaceutical industry start sourcing pharmaceuticals in China? After her presentation at the Made in America trade show last month, I met Rosemary Gibson, co-author with Janardan Prasad Singh of China RX, published in 2018. China RX is an expose of the pharmaceutical industry just as Death by China by Greg Autry and…